Profit

Buy Glenmark, hold Cipla shares: Nirmal Bang

PUBLISHED ON: August 2, 2012 | Duration: 4 min, 58 sec

  
loading..
Praful Bohra, Sr. Research Analyst - Pharmaceuticals at Nirmal Bang Institutional Equities speaks about the pharma sector. He advises investors to hold Cipla shares with a target of Rs 379 and buy Glenmark shares with a target price of Rs 462.
ALSO WATCH
Moderna Approved For Emergency Use, 4th Vaccine Okayed By India

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com